Cargando…
Small Intestinal Bacterial Overgrowth as Potential Therapeutic Target in Parkinson’s Disease
Increasing evidence suggests that the gut microbiota and the brain are closely connected via the so-called gut–brain axis. Small intestinal bacterial overgrowth (SIBO) is a gut dysbiosis in which the small intestine is abundantly colonized by bacteria that are typically found in the colon. Though no...
Autores principales: | Dănău, Adela, Dumitrescu, Laura, Lefter, Antonia, Tulbă, Delia, Popescu, Bogdan Ovidiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584211/ https://www.ncbi.nlm.nih.gov/pubmed/34769091 http://dx.doi.org/10.3390/ijms222111663 |
Ejemplares similares
-
Serum and Fecal Markers of Intestinal Inflammation and Intestinal Barrier Permeability Are Elevated in Parkinson’s Disease
por: Dumitrescu, Laura, et al.
Publicado: (2021) -
Serum Uric Acid Levels in Parkinson’s Disease: A Cross-Sectional Electronic Medical Record Database Study from a Tertiary Referral Centre in Romania
por: Dănău, Adela, et al.
Publicado: (2022) -
Shared Molecular Targets in Parkinson’s Disease and Arterial Hypertension: A Systematic Review
por: Tulbă, Delia, et al.
Publicado: (2022) -
Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management
por: Rao, Satish S. C., et al.
Publicado: (2019) -
Epidemiology of small intestinal bacterial overgrowth
por: Efremova, Irina, et al.
Publicado: (2023)